The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Dermatofibrosarcoma protuberans (DFSP) is rare, comprising (1%‐6%) of all sarcomas. The incidence is less than one per million before the age of 20. It is a locally aggressive tumor with a low risk of metastasis. We share our experience in the management of three pediatric patients with complex cases of DFSP in a combined surgical approach involving plastic and dermatologic surgery, using the slow...
The incidence of skin cancer is increasing dramatically worldwide, and with heightened public awareness, patients present with skin cancers at an earlier stage. Although most non-melanoma skin cancers occur on exposed sites, potentially lethal malignant melanoma tends to occur under clothing. Complete skin examination allows the detection of the lesion the patient presents with and any other the physician...
Skin cancer is the most common cancer in the UK, and incidence rates are continuing to increase. We discuss the common presentations, clinical features, referral guidelines, management and prognosis of both non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) and melanoma.
J Oral Pathol Med (2011) 40: 616–620
Pemphigus vulgaris (PV) is a life‐threatening autoimmune blistering disease affecting the skin and mucosa and is associated with increased morbidity and mortality. Once the diagnosis is established, the main stay of treatment of PV is with systemic corticosteroids to control the disease and then to consolidate the management with other immunosuppressive agents...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.